Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Tomasoni

Showing results (171-180 of 202) with videos related to

Pageof 21
Sort By:
JACC. Heart Failure|May 13, 2024
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of RiskAndrew P Ambrosy, Alex J Chang, Beth Davison, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]Aldostefano Porcari, Cristina Chimenti, Marco Merlo, et al.
Journal of the American College of Cardiology|July 17, 2024
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HFJan Biegus, Alexandre Mebazaa, Beth Davison, et al.
Journal of the American College of Cardiology|June 12, 2024
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Francesco Cappelli, Christian Nitsche, et al.
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
European Journal of Heart Failure|May 29, 2023
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trialMattia Arrigo, Jan Biegus, Ayu Asakage, et al.
JACC. Advances|February 21, 2025
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF TrialPeder L Myhre, Avishay Grupper, Alexandre Mebazaa, et al.
European Journal of Heart Failure|June 14, 2024
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HFGeert Voordes, Beth Davison, Jan Biegus, et al.
European Journal of Heart Failure|March 6, 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trialMatteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, et al.
JACC. Cardiovascular Imaging|December 8, 2022
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral RegurgitationMarianna Adamo, Riccardo Maria Inciardi, Daniela Tomasoni, et al.
Pageof 21

Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
JACC. Heart Failure|May 13, 2024
Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of RiskAndrew P Ambrosy, Alex J Chang, Beth Davison, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]Aldostefano Porcari, Cristina Chimenti, Marco Merlo, et al.
Journal of the American College of Cardiology|July 17, 2024
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HFJan Biegus, Alexandre Mebazaa, Beth Davison, et al.
Journal of the American College of Cardiology|June 12, 2024
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Francesco Cappelli, Christian Nitsche, et al.
American Heart Journal|May 13, 2024
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trialMattia Arrigo, Beth Davison, Christopher Edwards, et al.
European Journal of Heart Failure|May 29, 2023
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trialMattia Arrigo, Jan Biegus, Ayu Asakage, et al.
JACC. Advances|February 21, 2025
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF TrialPeder L Myhre, Avishay Grupper, Alexandre Mebazaa, et al.
European Journal of Heart Failure|June 14, 2024
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HFGeert Voordes, Beth Davison, Jan Biegus, et al.
European Journal of Heart Failure|March 6, 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trialMatteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, et al.
JACC. Cardiovascular Imaging|December 8, 2022
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral RegurgitationMarianna Adamo, Riccardo Maria Inciardi, Daniela Tomasoni, et al.
Pageof 21